ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,131.60
      0.64%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.985
      -0.36%
      Bitcoin
      67,086.68
      -1.57%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vir Biotechnology Inc (VIR)

      7. Vir Biotechnology Inc (VIR) Financials

      Vir Biotechnology Inc

      Vir Biotechnology Inc (VIR)

      Vidrala SA
      10.03
      -0.19
      (-1.86%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      10.03
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Vir Biotechnology Inc Financial Summary

      The current VIR market cap is 1.36B. The company's latest EPS is USD -4.5206 and P/E is -2.22.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 62.96M3.8M2.64M16.79M56.38M
      Operating Income -143.37M-215.19M-186.73M-131.32M-80.08M
      Net Income -140.9M-194.78M-163.41M-115.97M-65.28M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 8.09M76.37M1.1B1.62B86.18M
      Operating Income -177.98M-296.98M420.75M833.07M-676.61M
      Net Income -174.68M-298.67M528.58M515.84M-615.06M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.67B2.24B2.04B1.92B1.79B
      Total Liabilities 695.14M433.67M369.81M328.82M246.61M
      Total Equity 1.97B1.81B1.68B1.59B1.55B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 512.07M918.76M1.95B2.8B1.92B
      Total Liabilities 88.13M201.91M522.42M724.13M328.82M
      Total Equity 423.94M716.85M1.43B2.08B1.59B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -125.78M-515.03M-670.86M-778.79M-109.39M
      Investing 98.08M328.39M269.44M164.63M28.42M
      Financing 2.34M5.52M5.8M7.48M152k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -129.63M-190.94M-47.59M1.66B-778.79M
      Investing -256.16M-9.86M-140.81M-1.19B164.63M
      Financing 449.24M529.47M100.33M34.76M7.48M

      Stats and Ratios

      Market Cap 1.36B
      Price to Earnings Ratio -2.22
      Price to Sales Ratio 15.84
      Price to Cash Ratio 5.65
      Price to Book Ratio 0.86
      Dividend Yield -

      Share Statistics

      Shares Outstanding 136.06M
      Average Volume (1 week) 1M
      Average Volume (1 Month) 1.02M
      52 Week Change -29.12%
      52 Week High 14.4497
      52 Week Low 7.61
      Spread (Intraday) 2.04 (18.91%)

      Company Info

      Company Name Vir Biotechnology Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.vir.bio
      Industry biological pds,ex diagnstics (2836)